Grading Strength of Recommendations and Quality of Evidence in Clinical GuidelinesGordon Guyatt, Holger J. Schünemann, David D. Gutterman et al.|CHEST Journal|2006Cited by 1.2k
ADAMTS13 activity in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patientsSara K. Vesely, Gary E. Raskob|Blood|2003Cited by 674
Hemorrhagic Complications of Anticoagulant TreatmentMark N. Levine, Sam Schulman, Gary E. Raskob et al.|CHEST Journal|2004Cited by 513
Thrombosis in Cancer: Research Priorities Identified by a National Cancer Institute/National Heart, Lung, and Blood Institute Strategic Working GroupNigel S. Key, Anil K. Sood, Alok A. Khorana et al.|Cancer Research|2016Cited by 35